Editorial: Therapeutic potential of the cannabinoid CB2 receptor
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1039564/full |
| _version_ | 1828106474088300544 |
|---|---|
| author | Reem Smoum Uwe Grether Meliha Karsak Andrea J. Vernall Frank Park Cecilia J. Hillard Pal Pacher |
| author_facet | Reem Smoum Uwe Grether Meliha Karsak Andrea J. Vernall Frank Park Cecilia J. Hillard Pal Pacher |
| author_sort | Reem Smoum |
| collection | DOAJ |
| first_indexed | 2024-04-11T10:17:24Z |
| format | Article |
| id | doaj.art-91648edd20fd4d4880fc5daf2c89b600 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-11T10:17:24Z |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-91648edd20fd4d4880fc5daf2c89b6002022-12-22T04:29:54ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-10-011310.3389/fphar.2022.10395641039564Editorial: Therapeutic potential of the cannabinoid CB2 receptorReem Smoum0Uwe Grether1Meliha Karsak2Andrea J. Vernall3Frank Park4Cecilia J. Hillard5Pal Pacher6School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, IsraelRoche Innovation Center Basel, F. Hoffman-La Roche Ltd., Basel, SwitzerlandNeuronal and Cellular Signal Transduction, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Chemistry, University of Otago, Dunedin, New ZealandDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United StatesDepartment of Pharmacology and Toxicology, Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI, United StatesLaboratory of Cardiovascular Physiology and Tissue Injury, National Institute of Health/NIAAA, Rockville, MD, United Stateshttps://www.frontiersin.org/articles/10.3389/fphar.2022.1039564/fullCB2RCB2R ligandsinflammationneurodegenarative diseasesaddiction |
| spellingShingle | Reem Smoum Uwe Grether Meliha Karsak Andrea J. Vernall Frank Park Cecilia J. Hillard Pal Pacher Editorial: Therapeutic potential of the cannabinoid CB2 receptor Frontiers in Pharmacology CB2R CB2R ligands inflammation neurodegenarative diseases addiction |
| title | Editorial: Therapeutic potential of the cannabinoid CB2 receptor |
| title_full | Editorial: Therapeutic potential of the cannabinoid CB2 receptor |
| title_fullStr | Editorial: Therapeutic potential of the cannabinoid CB2 receptor |
| title_full_unstemmed | Editorial: Therapeutic potential of the cannabinoid CB2 receptor |
| title_short | Editorial: Therapeutic potential of the cannabinoid CB2 receptor |
| title_sort | editorial therapeutic potential of the cannabinoid cb2 receptor |
| topic | CB2R CB2R ligands inflammation neurodegenarative diseases addiction |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.1039564/full |
| work_keys_str_mv | AT reemsmoum editorialtherapeuticpotentialofthecannabinoidcb2receptor AT uwegrether editorialtherapeuticpotentialofthecannabinoidcb2receptor AT melihakarsak editorialtherapeuticpotentialofthecannabinoidcb2receptor AT andreajvernall editorialtherapeuticpotentialofthecannabinoidcb2receptor AT frankpark editorialtherapeuticpotentialofthecannabinoidcb2receptor AT ceciliajhillard editorialtherapeuticpotentialofthecannabinoidcb2receptor AT palpacher editorialtherapeuticpotentialofthecannabinoidcb2receptor |